Modakafusp Alfa
Modakafusp Alfa Uses, Dosage, Side Effects, Food Interaction and all others data.
Modakafusp Alfa is under investigation in clinical trial NCT03215030 (A Study to Investigate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of TAK-573 in Participants With Refractory Multiple Myeloma (MM)).
| Trade Name | Modakafusp Alfa |
| Generic | Modakafusp alfa |
| Modakafusp alfa Other Names | Anti-CD38-targeted IGG4-attenuated IFNA TAK-573, Modakafusp alfa |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Modakafusp Alfa
